☰

Patricia J. Keller, Ph.D. - Publications

Affiliations: 
2005 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Pharmacology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Conery AR, Park S, Steinbaugh MJ, Bryant BM, Apte S, Keller PJ, Yuan CC, Bradley B, Bommi-Reddy A, Sims RJ. Abstract 4351: Single-cell RNA sequencing reveals transcriptomic heterogeneity in response to epigenetic inhibitors Cancer Research. 79: 4351-4351. DOI: 10.1158/1538-7445.Am2019-4351  0.356
2016 Keller PJ, Conery AR, Centore RC, Bommi-Reddy A, Gascoigne KE, Bryant BM, Mertz JA, Sims RJ. Abstract 4749: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma Cancer Research. 76: 4749-4749. DOI: 10.1158/1538-7445.Am2016-4749  0.333
2009 Madigan JP, Bodemann BO, Brady DC, Dewar BJ, Keller PJ, Leitges M, Philips MR, Ridley AJ, Der CJ, Cox AD. Regulation of Rnd3 localization and function by protein kinase C alpha-mediated phosphorylation. The Biochemical Journal. 424: 153-61. PMID 19723022 DOI: 10.1042/Bj20082377  0.644
2008 Roberts PJ, Mitin N, Keller PJ, Chenette EJ, Madigan JP, Currin RO, Cox AD, Wilson O, Kirschmeier P, Der CJ. Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. The Journal of Biological Chemistry. 283: 25150-63. PMID 18614539 DOI: 10.1074/Jbc.M800882200  0.562
2007 Thomas EK, Cancelas JA, Chae HD, Cox AD, Keller PJ, Perrotti D, Neviani P, Druker BJ, Setchell KD, Zheng Y, Harris CE, Williams DA. Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease. Cancer Cell. 12: 467-78. PMID 17996650 DOI: 10.1016/J.Ccr.2007.10.015  0.528
2007 Thomas EK, Cancelas JA, Chae H, Cox AD, Keller PJ, Perrotti D, Neviani P, Druker BJ, Zheng Y, Harris CE, Williams DA. Rac GTPases Are Potential Therapeutic Targets in p210-BCR-ABL-Induced Myeloproliferative Disease (MPD). Blood. 110: 465-465. DOI: 10.1182/Blood.V110.11.465.465  0.54
2006 Fiordalisi JJ, Keller PJ, Cox AD. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Research. 66: 3153-61. PMID 16540666 DOI: 10.1158/0008-5472.Can-05-3116  0.557
2005 Keller PJ, Fiordalisi JJ, Berzat AC, Cox AD. Visual monitoring of post-translational lipid modifications using EGFP-GTPase probes in live cells. Methods (San Diego, Calif.). 37: 131-37. PMID 16288891 DOI: 10.1016/J.Ymeth.2005.05.023  0.512
2005 Keller PJ, Gable CM, Wing MR, Cox AD. Rac3-mediated transformation requires multiple effector pathways. Cancer Research. 65: 9883-90. PMID 16267012 DOI: 10.1158/0008-5472.Can-04-3116  0.541
Show low-probability matches.